Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 4
1973 1
1974 2
1975 5
1977 1
1978 1
1979 1
1986 3
1988 1
1989 2
1990 2
1991 1
1992 2
1993 1
1994 1
1996 2
1999 2
2000 3
2001 4
2002 13
2003 4
2004 11
2005 10
2006 18
2007 12
2008 12
2009 15
2010 12
2011 14
2012 25
2013 28
2014 21
2015 29
2016 16
2017 24
2018 21
2019 15
2020 21
2021 14
2022 12
2023 15
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

370 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018.
Bylicki O, Tomasini P, Radj G, Guisier F, Monnet I, Ricordel C, Bigay-Game L, Geier M, Chouaid C, Daniel C, Swalduz A, Toffart AC, Doubre H, Peloni JM, Moreau D, Subtil F, Grellard JM, Castera M, Clarisse B, Martins-Lavinas PH, Decroisette C, Greillier L; GFPC. Bylicki O, et al. Among authors: geier m. Eur J Cancer. 2023 Apr;183:38-48. doi: 10.1016/j.ejca.2023.01.014. Epub 2023 Jan 31. Eur J Cancer. 2023. PMID: 36801605 Free article. Clinical Trial.
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Baize N, Monnet I, Greillier L, Geier M, Lena H, Janicot H, Vergnenegre A, Crequit J, Lamy R, Auliac JB, Letreut J, Le Caer H, Gervais R, Dansin E, Madroszyk A, Renault PA, Le Garff G, Falchero L, Berard H, Schott R, Saulnier P, Chouaid C; Groupe Français de Pneumo-Cancérologie 01–13 investigators. Baize N, et al. Among authors: geier m. Lancet Oncol. 2020 Sep;21(9):1224-1233. doi: 10.1016/S1470-2045(20)30461-7. Lancet Oncol. 2020. PMID: 32888454 Clinical Trial.
Cerebral hypoperfusion in autism spectrum disorder.
Bjørklund G, Kern JK, Urbina MA, Saad K, El-Houfey AA, Geier DA, Chirumbolo S, Geier MR, Mehta JA, Aaseth J. Bjørklund G, et al. Among authors: geier mr. Acta Neurobiol Exp (Wars). 2018;78(1):21-29. Acta Neurobiol Exp (Wars). 2018. PMID: 29694338 Review.
Human Enzymes for Organic Synthesis.
Winkler M, Geier M, Hanlon SP, Nidetzky B, Glieder A. Winkler M, et al. Among authors: geier m. Angew Chem Int Ed Engl. 2018 Oct 8;57(41):13406-13423. doi: 10.1002/anie.201800678. Epub 2018 Sep 11. Angew Chem Int Ed Engl. 2018. PMID: 29600541 Free PMC article. Review.
Relevance of Neuroinflammation and Encephalitis in Autism.
Kern JK, Geier DA, Sykes LK, Geier MR. Kern JK, et al. Among authors: geier mr. Front Cell Neurosci. 2016 Jan 19;9:519. doi: 10.3389/fncel.2015.00519. eCollection 2015. Front Cell Neurosci. 2016. PMID: 26834565 Free PMC article. Review.
A critique that misses the mark.
Geier DA, Kern JK, Homme KG, Geier MR. Geier DA, et al. Among authors: geier mr. Int J Hyg Environ Health. 2019 Mar;222(2):309-310. doi: 10.1016/j.ijheh.2018.11.006. Int J Hyg Environ Health. 2019. PMID: 30850066 No abstract available.
Towards systems metabolic engineering in Pichia pastoris.
Schwarzhans JP, Luttermann T, Geier M, Kalinowski J, Friehs K. Schwarzhans JP, et al. Among authors: geier m. Biotechnol Adv. 2017 Nov 1;35(6):681-710. doi: 10.1016/j.biotechadv.2017.07.009. Epub 2017 Jul 29. Biotechnol Adv. 2017. PMID: 28760369 Review.
Refined Pichia pastoris reference genome sequence.
Sturmberger L, Chappell T, Geier M, Krainer F, Day KJ, Vide U, Trstenjak S, Schiefer A, Richardson T, Soriaga L, Darnhofer B, Birner-Gruenberger R, Glick BS, Tolstorukov I, Cregg J, Madden K, Glieder A. Sturmberger L, et al. Among authors: geier m. J Biotechnol. 2016 Oct 10;235:121-31. doi: 10.1016/j.jbiotec.2016.04.023. Epub 2016 Apr 12. J Biotechnol. 2016. PMID: 27084056 Free PMC article. Review.
Thimerosal: clinical, epidemiologic and biochemical studies.
Geier DA, King PG, Hooker BS, Dórea JG, Kern JK, Sykes LK, Geier MR. Geier DA, et al. Among authors: geier mr. Clin Chim Acta. 2015 Apr 15;444:212-20. doi: 10.1016/j.cca.2015.02.030. Epub 2015 Feb 21. Clin Chim Acta. 2015. PMID: 25708367 Free article. Review.
370 results